ICOS is critical for CD40-mediated antibody class switching
Alexander J. McAdam(Harvard University), Rebecca J. Greenwald(Brigham and Women's Hospital), Michele A. Levin(Harvard University), Tatyana Chernova(Dana-Farber Cancer Institute), Nelly Malenkovich(Dana-Farber Cancer Institute), Vincent Ling(Reproductive Genetics Institute), Gordon J. Freeman(Dana-Farber Cancer Institute), Arlene H. Sharpe(Brigham and Women's Hospital)
Cited by 644